Evidence map›Paper›PMID 38038121›Full record

ArticleMolecular medicine reports2024

Ran Sun, Min Han, Yan Liu, Yong Su, Qifeng Shi, Lei Huang, Liangliang Kong, Weizu Li, Weiping Li

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. TRPC6-Mediated CaCells · 2026
    Article
  3. Article
  4. Upregulation of Piezo2 and increased extracellular matrix protein in diabetic kidney disease mice.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  5. Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy.Journal of the American Society of Nephrology : JASN · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ran Sun *Department of Pharmacology, Grade III Laboratory of National Administration of Traditional Chinese Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Min Han *Department of Pharmacology, Grade III Laboratory of National Administration of Traditional Chinese Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Yan Liu *Department of Pharmacology, Grade III Laboratory of National Administration of Traditional Chinese Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Yong SuDepartment of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Qifeng ShiDepartment of Pharmacology, Grade III Laboratory of National Administration of Traditional Chinese Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Lei HuangDepartment of Pharmacology, Grade III Laboratory of National Administration of Traditional Chinese Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Liangliang KongDepartment of Pharmacology, Grade III Laboratory of National Administration of Traditional Chinese Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Weizu LiDepartment of Pharmacology, Grade III Laboratory of National Administration of Traditional Chinese Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Weiping LiDepartment of Pharmacology, Grade III Laboratory of National Administration of Traditional Chinese Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic kidney disease (DKD), one of the common complications of type‑2 diabetes mellitus (T2DM), has become the principal cause of end‑stage kidney disease. Transient receptor potential channel 6 (TRPC6), one of non‑selective cation channels with significant calcium‑permeability, is associated with renal fibrosis. However, the mechanism of TRPC6 in T2DM‑induced renal fibrosis is still not entirely understood. The present study explored the potential mechanism of

Indexed as

Diabetes Mellitus, Type 2Diabetic NephropathiesAnimalsCalcineurinCalciumFibrosisMiceMice, KnockoutSignal TransductionTRPC6 Cation ChannelTRPC Cation ChannelsCalcineurinCalciumTRPC6 Cation ChannelTrpc6 protein, mouseTRPC Cation ChannelsNod‑like receptor protein 3 inflammasomenuclear factor of activated T‑cell 2renal fibrosistransient receptor potential channel 6type‑2 diabetes mellitus

Identifiers

PMID38038121
PMCPMC10704556
OpenAlexW4389048990

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.